
Eva 35 2mg/0.035mg Tablet
Marketer
Olcare Laboratories
Salt Composition
Cyproterone (2mg) + Ethinyl Estradiol (0.035mg)
Overview Eva 35 2mg/0.035mg Tablet
Combifem 2mg/0.035mg tablets, a dual-hormone medication, alleviate PCOS symptoms like excess hair, acne, and menstrual irregularities. Its contraceptive properties necessitate avoiding additional birth control. This medication can be ingested with or without food, consistently at the same time daily for optimal adherence. Dosage and treatment length are individualized; always finish the prescribed course. Common side effects include nausea, abdominal discomfort, headaches, weight increase, and breast tenderness. Report any concerning or persistent symptoms to your physician; management strategies exist. Consult your doctor for frequent mid-cycle spotting or brown discharge. Seek immediate medical attention for unexplained limb swelling, pain, breathlessness, chest pain, or vision changes. Discontinue use and contact your physician if menstruation doesn't begin within seven days of treatment. Inform your doctor of all other medications you are using, as interactions may reduce efficacy or alter effects. Avoid this medicine during pregnancy and breastfeeding.
Uses of Eva 35 2mg/0.035mg Tablet
Managing Polycystic Ovary Syndrome (PCOS)
Major Benefits of Eva 35 2mg/0.035mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Eva 35 2mg/0.035mg tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Eva 35 2mg/0.035mg Tablet:
- Nausea
- Stomach pain
- Headache
- Weight gain
- Breast pain
- Mood changes
How to use Eva 35 2mg/0.035mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Eva 35 2mg/0.035mg tablets can be consumed with or without food, however, consistent daily timing is recommended.
How Eva 35 2mg/0.035mg Tablet works:
Eva 35, a 2mg/0.035mg tablet, combines Cyproterone and Ethinyl Estradiol to manage Polycystic Ovary Syndrome (PCOS) symptoms. This dual-hormone approach addresses acne, excessive hair (hirsutism), and irregular menstruation. Cyproterone's action involves suppressing ovarian androgen overproduction, thus mitigating acne and unwanted hair growth. Ethinyl Estradiol complements this by lowering circulating androgens, further improving efficacy. The combined effect also normalizes menstrual cycles in women with PCOS.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Eva 35 2mg/0.035mg Tablet concurrently with alcohol. Seek medical advice before combining them.
PregnancyUNSAFE
Using Eva 35 2mg/0.035mg tablets during pregnancy is strongly contraindicated. Pregnant women should consult their physician; research in both animal and human studies indicates substantial risks to fetal development.
Breast feedingCONSULT YOUR DOCTOR
The use of Eva 35 2mg/0.035mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by taking Eva 35 2mg/0.035mg tablets.
KidneyCONSULT YOUR DOCTOR
Data regarding the use of Eva 35 2mg/0.035mg tablets in individuals with renal impairment is scarce. Seek medical advice from your physician.
LiverCONSULT YOUR DOCTOR
Data regarding the use of Eva 35 2mg/0.035mg tablets in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Eva 35 2mg/0.035mg Tablet :
Should you forget to take your Eva 35 2mg/0.035mg Tablet, administer it immediately upon remembering. If, however, your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Eva 35 2mg/0.035mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | OBSTETRICS AND GYNECOLOGY |
